Ending the tuberculosis syndemic: is COVID-19 the (in)convenient scapegoat for poor progress?. Rangaka, M. X, Hamada, Y., & Abubakar, I. The Lancet Respiratory Medicine, 10(6):529–531, Elsevier, mar, 2022.
Ending the tuberculosis syndemic: is COVID-19 the (in)convenient scapegoat for poor progress? [link]Paper  doi  bibtex   
@article{Rangaka2022,
author = {Rangaka, Molebogeng X and Hamada, Yohhei and Abubakar, Ibrahim},
doi = {10.1016/S2213-2600(22)00123-0},
file = {:C$\backslash$:/Users/01462563/AppData/Local/Mendeley Ltd./Mendeley Desktop/Downloaded/Rangaka, Hamada, Abubakar - 2022 - Ending the tuberculosis syndemic is COVID-19 the (in)convenient scapegoat for poor progress.pdf:pdf},
isbn = {2022.103939},
issn = {2213-2600},
journal = {The Lancet Respiratory Medicine},
keywords = {commentary,fund{\_}not{\_}ack},
mendeley-tags = {commentary,fund{\_}not{\_}ack},
month = {mar},
number = {6},
pages = {529--531},
pmid = {35338839},
publisher = {Elsevier},
title = {{Ending the tuberculosis syndemic: is COVID-19 the (in)convenient scapegoat for poor progress?}},
url = {http://www.thelancet.com/article/S2213260022001230/fulltext http://www.thelancet.com/article/S2213260022001230/abstract https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(22)00123-0/abstract},
volume = {10},
year = {2022}
}

Downloads: 0